Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells

被引：0
|
作者：
Annick Mühlethaler-Mottet
Roland Meier
Marjorie Flahaut
Katia Balmas Bourloud
Katya Nardou
Jean-Marc Joseph
Nicole Gross
机构：
[1] University Hospital CHUV,Paediatric Oncology Research, Paediatric Department
[2] University of California,Life Sciences Division, Lawrence Berkeley National Laboratory
[3] University Hospital CHUV,Paediatric Surgery, Paediatric Department
来源：
Molecular Cancer | / 7卷
关键词：
Cell Cycle Arrest; SAHA; Survivin Expression; Sodium Butyrate; Lactacystin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
    Albertsson, PA
    Basse, PH
    Hokland, M
    Goldfarb, RH
    Nagelkerke, JF
    Nannmark, U
    Kuppen, PJK
    TRENDS IN IMMUNOLOGY, 2003, 24 (11) : 603 - 609
  • [42] Inhibitors of histone deacetylase, valproic acid and trichostatin A, increase cytotoxicity of anticancer drug ellipticine to neuroblastoma cells
    Hrabeta, Jan
    Poljakova, Jitka
    Frei, Eva
    Stiborova, Marie
    Eckschlager, Tomas
    CANCER RESEARCH, 2009, 69
  • [43] Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
    N Ioannou
    A G Dalgleish
    A M Seddon
    D Mackintosh
    U Guertler
    F Solca
    H Modjtahedi
    British Journal of Cancer, 2011, 105 : 1554 - 1562
  • [44] Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
    Ioannou, N.
    Dalgleish, A. G.
    Seddon, A. M.
    Mackintosh, D.
    Guertler, U.
    Solca, F.
    Modjtahedi, H.
    BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1554 - 1562
  • [45] Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
    Heimburg, Tino
    Kolbinger, Fiona R.
    Zeyen, Patrik
    Ghazy, Ehab
    Herp, Daniel
    Schmidtkunz, Karin
    Melesina, Jelena
    Shaik, Tajith Baba
    Erdmann, Frank
    Schmidt, Matthias
    Romier, Christophe
    Robaa, Dina
    Witt, Olaf
    Oehme, Ina
    Jung, Manfred
    Sippl, Wolfgang
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (24) : 10188 - 10204
  • [46] The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity
    Kaneda, Daisuke
    Iehara, Tomoko
    Kikuchi, Ken
    Sugimoto, Yohei
    Nakagawa, Norio
    Yagyu, Shigeki
    Miyachi, Mitsuru
    Konishi, Eiichi
    Sakai, Toshiyuki
    Hosoi, Hajime
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [47] Comment on 'Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'
    Ji, Y.
    Chen, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 2022 - 2023
  • [48] Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma’
    Y Ji
    S Chen
    British Journal of Cancer, 2013, 109 : 2022 - 2023
  • [49] Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
    Yang, Chunzhang
    Rahimpour, Shervin
    Lu, Jie
    Pacak, Karel
    Ikejiri, Barbara
    Brady, Roscoe O.
    Zhuang, Zhengping
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (03) : 966 - 971
  • [50] Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
    Gabrielli, B. G.
    Johnstone, R. W.
    Saunders, N. A.
    CURRENT CANCER DRUG TARGETS, 2002, 2 (04) : 337 - 353
12345